<code id='4D7B181ED7'></code><style id='4D7B181ED7'></style>
    • <acronym id='4D7B181ED7'></acronym>
      <center id='4D7B181ED7'><center id='4D7B181ED7'><tfoot id='4D7B181ED7'></tfoot></center><abbr id='4D7B181ED7'><dir id='4D7B181ED7'><tfoot id='4D7B181ED7'></tfoot><noframes id='4D7B181ED7'>

    • <optgroup id='4D7B181ED7'><strike id='4D7B181ED7'><sup id='4D7B181ED7'></sup></strike><code id='4D7B181ED7'></code></optgroup>
        1. <b id='4D7B181ED7'><label id='4D7B181ED7'><select id='4D7B181ED7'><dt id='4D7B181ED7'><span id='4D7B181ED7'></span></dt></select></label></b><u id='4D7B181ED7'></u>
          <i id='4D7B181ED7'><strike id='4D7B181ED7'><tt id='4D7B181ED7'><pre id='4D7B181ED7'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          hotspot

          author:leisure time    - browse:1495
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus